61. Welcome To Hemophilia Health Services Home About Us FactorCare Why HHS Bleeding Disorders Bloodstone Magazine Just For Kids Terms ©Copyright 2002 hemophilia Health Services, Inc. http://www.accredohealth.net/hhs/

Home About Us FactorCare Why HHS Home About Us FactorCare Why HHS ... Terms

62. MSN Learning & Research - Hemophilia hemophilia, hereditary blood disease involving the inability of blood to clot, or coagulate, leading to hemorrhage, or bleeding. http://encarta.msn.com/encnet/refpages/RefArticle.aspx?refid=761570021

63. Hemophilia - Bayer Pharmaceutical Home What is hemophilia? Berkeley, CA Clayton, NC Resources Feedback Products. LatestNews Product Literature. Journal of hemophilia Reports. The Parents Resource http://www.hemophiliabayer.com/

Home What is Hemophilia? Berkeley, CA Clayton, NC ... New Hand-Held Computer Technology Improves Management of Chronic, Life-Threatening Bleeding Disorders; Bayer Biological Products Acquires Rights for Use in Hemophilia Clinical Questions? Call our Clinical Communications Dept. (select option #1) Peer Reviewed Literature Bayer sponsored programs Kids On The Block Interactive TeleClinic Product Literature Journal of Hemophilia Reports Parents Empowering Parents The PEP Program Parents' Frequently Asked Questions Patient Notification System PPTA Slide Presentation: "Inside A Bleeding Joint" Glossary of Hemophilia Related Words Children's Activity Book Slide Presentation: "Inside A Bleeding Joint" Links to Fun Stuff Click here for hemophilia treatment product information Home Health Care Providers Parents Children ... Privacy Statement

64. Choice Source Therapeutics Provide hemophilia care for patients. http://www.choicesource.com

About Us Services Contacts Resources About Us Services Contacts Resources ... Español

65. Hemophilia - Bayer Pharmaceutical - What Is Hemophilia? Clinical Questions? Call our Clinical Communications Dept. 1800-288-8371 (selectoption 1). What is hemophilia? hemophilia CARE IN THE UNITED STATES. http://www.hemophiliabayer.com/What_is_Hemophilia_/what_is_hemophilia_.html

Home What is Hemophilia? Berkeley, CA Clayton, NC ... Products Clinical Questions? Call our Clinical Communications Dept. (select option #1) What is Hemophilia? Definition Hemophilia is a genetic disorder characterized by the deficiency or absence of one of the proteins (or factors) in blood plasma that is responsible for clotting. Low levels of one of these plasma proteins result in bleeding and difficulty clotting in the affected individual. There are more than a dozen clotting factors in our bodies. The most common deficiency of a clotting protein is factor VIII although any one of these can be deficient or absent. The second most common deficiency is Factor IX deficiency. There are factor VIII and IX concentrates that are manufactured to treat these two types of hemophilia. Treatment for hemophilia Manufacturers, like Bayer, have developed concentrates containing Factor VIII and IX clotting factors that are used for treatment of persons with hemophilia. These clotting factor concentrates are packaged in a freeze-dried form that requires reconstitution with sterile water before being infused into the vein of a person with hemophilia. Click here for information on Bayer Pharmaceutical's line of hemophilia products.

66. Canadian Hemophila Society: BC Chapter Information about the organization and its mission, news archive, links and contact details. Also an in depth look at the disease itself including management. http://www.hemophiliabc.ca

Home Our Mission Who We Are About Hemophilia News Archive ... Contact Latest News You are invited to join us on Friday, June 20, 2003, when we host the first annual BC Hemophilia Charity Golf Classic We tee off at Swan-E-Set Bay Resort and Country Club with a 12:30 shotgun start. After a round of golf and lunch, the day wraps up in style with a banquet dinner, speeches and charity auction. Come out as an individual golfer or really get into the game and enter your team of four to support the BC Chapter of the Canadian Hemophilia Society. Ongoing Events Our Charity Car Donation Program is a way for you to turn your unwanted vehicle into a cash donation for the Hemophilia Society of BC. A-Part Auto Wrecking will arrange for pick up of your car, processes the sale of your vehicle, and forwards the proceeds directly to Hemophilia BC. For more information please contact: A-Part Auto Wrecking Ltd . 13491 Mitchell Road Richmond, BC, V6V 1M7

67. HSC- Hemophilia Society Of Colorado HSC Home Page click here. http://www.cohemo.org/

HSC Home Page - click here HSC Home Page - click here

68. Tonya's Page This page is dedicated to my son, who has hemophilia. http://members.tripod.com/~TKCDAC/index-2.html

This page has moved to http://members.tripod.com/TKCDAC/index.html Please make a note of

69. HEMOPHILIA hemophilia. Background hemophilia is the oldest known hereditary bleedingdisorder. There are two types of hemophilia, A and B (Christmas Disease). http://www.nhlbi.nih.gov/health/public/blood/other/hemophel.htm

HEMOPHILIA Background Challenges : The most important challenges facing the hemophilia patient, health care provider, and research community today are: Safety of products used for treatment; Management of the disease including inhibitor formation, irreversible joint damage, and life-threatening hemorrhage; and Progress toward a cure. Safety of Products Used for Treatment : In the past 10 to 15 years, advances in screening of blood donors, laboratory testing of donated blood, and techniques to inactivate viruses in blood and blood products have remarkably increased the safety of blood products used to treat hemophilia. Although treatment-related infection with the AIDS virus or most of the hepatitis viruses is a thing of the past, these measures do not completely avoid viruses such as hepatitis A and parvo virus. These infections are rare; nevertheless, they can pose a threat. Researchers are working to improve procedures to destroy these viruses. To ensure absolute safety from transfusion-transmitted viruses and other agents, hemophiliacs may now be treated with factor VIII which has been produced through biotechnology. This product, recombinant factor VIII, is manufactured by a process entirely free of blood products. It, thus, contains only the factor VIII necessary to treat the disease and none of the other components of blood or attendant unwanted agents. Although the cost of this product exceeds that of the blood-derived product, it is clearly the treatment of choice for those, such as newborns, who have not yet been exposed to blood products. A factor IX product has also been produced by such a process and is currently in clinical trials. Once this product is shown to be safe and effective, all hemophiliacs will have available a treatment for bleeding which is totally free of any contaminating agents.

70. Gentiva Health Services - Page Not Found Designed to help you understand hemophilia, von Willebrand's disease and other bleeding disorders and provide valuable information. http://www.gentiva.com/consumer/hemophilia/

About Gentiva Services Investor Relations Career Opportunities ... gentiva.com Page Not Found We are sorry, but the URL you requested could not be found. The page you are looking for may have been renamed, moved, or deleted. If you feel you have reached this page in error, please use the Back button of your browser or check the address you entered and try again. If you reached this page from another part of gentiva.com, please let us know so we can fix the problem. Please check the URL for spelling, capitalization, and punctuation errors, and click the "reload" button on your browser. To view a current site map of gentiva.com click here , or to return to the gentiva.com home page click here Company Information Services Investor Relations ... Legal Statement

71. Hemophilia Update: 1997 hemophilia UPDATE 1997. Background effective. Antibody inhibitorsare more likely to occur in individuals with severe hemophilia. http://www.nhlbi.nih.gov/health/public/blood/other/hemo_97.htm

HEMOPHILIA UPDATE: 1997 Background Advances in treatment over the last three decades have permitted a near-normal lifestyle and life-span for many individuals with hemophilia. The introduction of factor VIII concentrate products in the 1970s allowed treatment at home and largely replaced the need for transfusion of whole blood or plasma in the hospital. An unfortunate result of increased freedom from bleeding as a cause of disability and death was infection with hepatitis from products made from pooled plasma. This culminated in the early 1980s with the unexpected and devastating infection of about 70 % of severe hemophiliac patients with HIV, the cause of AIDS. Since then, the development and improvement of methods for inactivating viruses with lipid envelopes in plasma, including factor VIII and IX concentrates, has improved the safety of transfused products to the point where the threat of infection with HIV, hepatitis B(HBV) or hepatitis C (HCV) viruses has been essentially eliminated. Safety of Products Used in Treatment Over the last few years, improved procedures have led to high purity plasma-derived factor VIII and factor IX products which appear to be safer when subjected to viral inactivation procedures than were the previous lower potency materials. "First generation" recombinant factor VIII, produced without human plasma, became available in 1992. This added a measure of safety especially from non-enveloped viruses, although the need for human albumen to stabilize the factor left a tiny and currently hypothetical risk of human infectious agent transmission. The first recombinant factor IX preparation is now in clinical trials. It is a "second generation" product which is manufactured and packaged without any human or animal plasma proteins. A similarly produced factor VIII concentrate is under development.

72. Hemophilia hemophilia. incidence knees elbows ankles hips shoulders wrists.results in secondary OA (DDx acromegaly, ochronosis, spondyloepiphyseal http://chorus.rad.mcw.edu/doc/01019.html

CHORUS Collaborative Hypertext of Radiology Musculoskeletal system Feedback Search hemophilia incidence: knees > elbows > ankles > hips > shoulders > wrists results in secondary OA (DDx: acromegaly ochronosis spondyloepiphyseal dysplasia , chronic trauma) xray manifestations: premature closure of epiphysis leading to short bone with enlarged end "squared" patella (flattened inferiorly) widened intercondylar notch subchondral cysts severe osteopenia Cf: JRA Brian Funaki, MD - 6 February 1995 Last updated 14 March 2001 Medical College of Wisconsin

73. Haemostasis Forum Dedicated to supplying information on haemophilia to medical and health care professionals, providing an excellent opportunity to interact with worldwide specialists in the field of haematology. http://www.hemophilia-forum.org/

This is a web site dedicated to supplying information on haemophilia to medical and health care professionals, providing an excellent opportunity to interact with worldwide specialists in the field of haematology. Each month the contents of these pages are updated and reviewed by a panel of independent haemophilia specialists. Please click on Faculty Info. This forum is supported by an educational grant from Novo Nordisk A/S. If you would like to access this site, please click on 'Register Now' and submit your details. If you have already registered, please enter your username and password and click on 'accept'. Enter your details here please User name: Password: Cancel Accept Preview this site Register ... Forgot Password

74. AHF - What Is Hemophilia? Disclaimer Privacy Policy. WHAT IS hemophilia? hemophilia is a disorder causedby an error in a person’s genetic code. hemophilia is a lifelong disorder. http://www.ahfinfo.com/ahfinfo/whatishemophilia.html

AHF, Inc. E-MAIL: info@ahfinfo.com AHF® Inc. Privacy Policy WHAT IS HEMOPHILIA? This special genetic code, passed to an unborn child, is supposed to signal a series of steps that help control bleeding by clotting. The steps needed to form a clot depend upon a series of proteins called factors. This error in genetic code means that some of the factors are missing or that they are not working correctly in a person with hemophilia. This causes people with hemophilia to bleed longer but not faster. Surface bleeds, on the outside of the body, are fairly easy to stop, even for people with hemophilia. Internal bleeding, such as bleeding into joints or muscles, can mean that it is only possible for a clot to form after the person has taken medication called clotting factor. More than 15,000 people have hemophilia A or hemophilia B in the United States. There are other bleeding disorders where one or more of the clotting factors is missing. People with hemophilia A are missing factor VIII and those with hemophilia B are missing factor IX, others may be missing factors I, II, VII, etc. There are also other bleeding disorders. The most common of which is von Willebrand disease, and many more people have von Willebrand disease than have hemophilia. Individuals with bleeding disorders can be missing a little, a lot, or almost all of that particular factor needed to form clots and stop bleeding. These are called mild, moderate, and severe levels of disorder. The level of severity will predict how often a person will develop a bleed, how difficult it will be for them to form a clot, and how much clotting medication they will need in order to form a clot.

75. Hemophilia, Clotting Factor, Infusion, Hemophilia Care, Von Willebrand Disease, Providing next-day hospital and home delivery of several blood products.Category Business Healthcare Products and Services Blood Products...... Care, von Willebrand disease. The hemophilia Disease Management Company31 Moody Road PO Box 985 Enfield, CT 06083 1-800-243-4621. http://www.ahfinfo.com/

The Hemophilia Disease Management Company 31 Moody Road - P.O. Box 985 Enfield, CT 06083 1-800-243-4621

76. Index Florida Chapter Of The National hemophilia Foundation, Inc. This pageis designed to pass information on to our community and to http://www.geocities.com/HotSprings/1809/

Florida Chapter National Hemophilia Foundation Links For Your Information Anyone not receiving our award winning newsletter can e-mail us your name and address at hemoph5011@aol.com . This newsletter has important and updated information plus activities going on around the state. The newsletter and this website are for you, so any input or links you feel should be on our list, please e-mail them to us including any of your personal webpages. If there is a picture or article you would like to include in our newsletter please e-mail it and it will get to our editor. We can always use your help. Don't forget to see who our sponsors are and visit their sites including Amazon.com and CD Now. Florida Chapter Newsletter Annual Membership Meeting Calendar Of Events Chapter's Officers and Board Members ... Photo Gallery Florida Chapter Home Office Numbers: Home Office: 1-727-856-7057 Fax: 1-727-856-2257 Toll Free - 1-888-880-8330 Links to Donations: Everytime you make a purchase through our Amazon link or CD NOW located below, a percentage of your purchase is donated to our Chapter. Thank you in advance! If you have comments or sugguestions, please feel free to e-mail us at

77. HAVEN HAVEN is an independent organization in Northwestern PA. W Provides patients and their families with information about their condition, treatment options and patient rights. http://members.tripod.com/haven8361/

var TlxPgNm='index'; HAVEN Hemophilia And VonWillebrand's Education Network Mission Vision History Bleeding Disorders Information ... Related Links Welcome to the HAVEN web site. HAVEN evolved from a support group started by the mother of a hemophiliac in Erie, PA in 1997. The support group now includes other affected individuals and families and is gaining the interest and support of the Erie community. The support group organized themselves and identified certain needs within the local Bleeding Disorders Community. HAVEN was created to help address those needs. HAVEN is an independent bleeding disorders association. We seek to provide patients and their families information about their condition, treatment options and patient rights. HAVEN can provide the patients and families with a variety of contacts within the hemophilia community. HAVEN (Hemophilia and von Willebrand’s Education Network) held the 2nd Thank you to the following for their support of the M a r d ... l: Click above for new photos added, 8/27/02 Aventis Behring L.L.C.

78. Welcome To The Utah Hemophilia Foundation http://www.hemophiliautah.org/

79. Bayer at Bayer Biological Products have been dedicated to developing and producing noveltreatments that extend and enhance the lives of people with hemophilia. http://www.bayer-hemophilia-awards.com/

For more than 30 years, scientists and researchers at Bayer Biological Products have been dedicated to developing and producing novel treatments that extend and enhance the lives of people with hemophilia. Bayer believes the Hemophilia Awards Program can improve the lives of patients with hemophilia by supporting research and education worldwide. The next steps for the next generation

80. GeneReviews: Hemophilia A Your browser does not support HTML frames so you must view hemophilia Ain a slightly less readable form. Please follow this link to do so. http://www.geneclinics.org/profiles/hemo-a/

Your browser does not support HTML frames so you must view Hemophilia A in a slightly less readable form. Please follow this link to do so.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 122    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | Next 20